Code Biotherapeutics

2:45 PM - 3:00 PM (PDT), Wednesday, June 15, 2022
Code Bio is developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Pennsylvania
Company HQ Country:
United States
Year Founded:
2021
Main Therapeutic Focus:
Lead Product in Development:
DMD & T1D Discovery Programs
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided